Simulations Plus (NASDAQ:SLP – Get Free Report) and SMS Alternatives (OTCMKTS:CICN – Get Free Report) are both computer and technology companies, but which is the superior stock? We will compare the two businesses based on the strength of their earnings, analyst recommendations, valuation, risk, dividends, institutional ownership and profitability.
Analyst Ratings
This is a summary of recent ratings for Simulations Plus and SMS Alternatives, as provided by MarketBeat.com.
Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
Simulations Plus | 0 | 2 | 4 | 0 | 2.67 |
SMS Alternatives | 0 | 0 | 0 | 0 | 0.00 |
Simulations Plus presently has a consensus price target of $26.50, suggesting a potential upside of 104.00%. Given Simulations Plus’ stronger consensus rating and higher possible upside, analysts plainly believe Simulations Plus is more favorable than SMS Alternatives.
Profitability
Net Margins | Return on Equity | Return on Assets | |
Simulations Plus | -78.63% | 11.62% | 10.84% |
SMS Alternatives | N/A | N/A | N/A |
Valuation and Earnings
This table compares Simulations Plus and SMS Alternatives”s revenue, earnings per share (EPS) and valuation.
Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
Simulations Plus | $70.01 million | 3.74 | $9.95 million | ($3.15) | -4.12 |
SMS Alternatives | N/A | N/A | N/A | N/A | N/A |
Simulations Plus has higher revenue and earnings than SMS Alternatives.
Institutional and Insider Ownership
78.1% of Simulations Plus shares are owned by institutional investors. 19.4% of Simulations Plus shares are owned by insiders. Comparatively, 89.0% of SMS Alternatives shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.
Summary
Simulations Plus beats SMS Alternatives on 7 of the 9 factors compared between the two stocks.
About Simulations Plus
Simulations Plus, Inc. develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. The company operates through two segments, Software and Services. It offers GastroPlus, which simulates the absorption and drug interaction of compounds administered to humans and animals; and DDDPlus and MembranePlus simulation products. The company also provides products based on mechanistic and mathematical models, such as DILIsym, NAFLDsym, ILDsym, RENAsym, IPFsym, and MITOsym products. In addition, it offers Absorption, Distribution, Metabolism, Excretion, and Toxicity Predictor for chemistry-based computer program that takes molecular structures as inputs and predicts their properties; and MedChem Designer, as well as MonolixSuite products for modeling and simulation that allows for population analyses, rapid clinical trial data analyses, and regulatory submissions. Further, the company provides clinical-pharmacology-based consulting services, which includes population pharmacokinetic and pharmacodynamic modeling, exposure-response analyses, clinical trial simulations, data programming, and technical writing services in support of regulatory submissions; and early drug discovery services. Additionally, it offers creative and insightful consulting services to support its quantitative systems pharmacology/quantitative systems toxicology modelling. The company serves pharmaceutical, biotechnology, agrochemical, cosmetics, and food industry companies, as well as academic and regulatory agencies. Simulations Plus, Inc. was incorporated in 1996 and is headquartered in Lancaster, California.
About SMS Alternatives
SMS Alternatives Inc. provides business integration software solutions in the United States and Europe. The company's software enables organizations to integrate new and existing information and processes at the desktop; and addresses the need for a company's information systems to deliver enterprise-wide views of their business information processes. It offers Cicero Discovery, a configurable tool to collect activity and application performance data, and track business objects across time and multiple users, as well as measure against a defined expected business process flow; and Cicero Insight, a measurement and analytics solution that collects and presents information about quality, productivity, compliance, and revenue from frontline activity to target areas for improvement. The company also provides Cicero Automation that delivers features of the Cicero Discovery product, as well as desktop automation for enterprise contact center and back office employees; integrates applications and automates workflow; and control and adaptability at the end user desktop. In addition, it offers technical support, training, and consulting services. The company sells its products and services directly, as well as through distributors and other intermediaries who resell it to end-users. It serves financial services, insurance, and telecommunications industries; and business process outsourcers, as well as intelligence, security, law enforcement, and other governmental organizations. The company was formerly known as Cicero Inc. and changed its name to SMS Alternatives Inc. in June 2023. SMS Alternatives Inc. was founded in 1988 and is headquartered in Cary, North Carolina.
Receive News & Ratings for Simulations Plus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Simulations Plus and related companies with MarketBeat.com's FREE daily email newsletter.